James Coyne “lays waste” to PACE trial in Edinburgh
Sasha summarises Professor James Coyne's recent no-holds-barred talk on the PACE trial and points you to the slides, video, audio and transcript.
Discuss the article on the Forums.

Article: Roche releases Phase III results of Rituximab on Lymphoma

Discussion in 'Rituximab: News and Research' started by HopingSince88, May 23, 2010.

  1. HopingSince88

    HopingSince88 Senior Member

    Messages:
    335
    Likes:
    6
    Maine
    "Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from the Phase III PRIMA study. The data showed that continuing MabThera (rituximab) for two years in patients who responded to initial treatment with MabThera plus chemotherapy, doubled the likelihood of them living without their disease worsening, known as progression-free survival (PFS), compared to those who did not receive maintenance."

    Link:

    http://www.roche.com/media/media_releases/med-cor-2010-05-21.htm
     
  2. camas

    camas Senior Member

    Messages:
    697
    Likes:
    223
    Oregon
    This is good news for those with follicular lymphoma.
     
  3. HopingSince88

    HopingSince88 Senior Member

    Messages:
    335
    Likes:
    6
    Maine

See more popular forum discussions.

Share This Page